Strepsils announces to appeal CCP’s decision
[Karachi, 13 February 2021] Competition Commission of Pakistan (CCP) has recently passed an order against Strepsils Comfort for alleged deceptive marketing, which we are now going to appeal.
The discussions with CCP are ongoing since December 2018, during which we have presented numerous third-party researches to substantiate our actions, specifically claims made on the effectiveness of Strepsils Comfort. However, CCP failed to consider our strong evidence and therefore we are now left with no other option but to appeal.
Honesty and transparency are fundamental operating principles for RB, and we ensure that our product positioning and communication is fair, honest and do not mislead consumers or is unclear in any manner. All objective claims used in our communication and in our packaging & promotional materials are backed by credible and documented evidence capable of withstanding scientific scrutiny and compliance with all local consumer laws.
We assure you that we are fully committed to protecting our consumers and will provide the best solutions that protect, heal and nurture for a healthier life.